000 | 01072na a2200229 4500 | ||
---|---|---|---|
999 |
_c5229 _d5229 |
||
003 | PC5229 | ||
005 | 20210625062802.0 | ||
008 | 130622s2013 xxx||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_aChaves Sánchez, Fernando _978 _eMicrobiología y Parasitología |
||
100 |
_aRodríguez Otero, Joaquín _9868 _eMicrobiología y Parasitología |
||
100 |
_aViedma Moreno, Esther _91616 _eInstituto de Investigación i+12 |
||
245 | 0 | 0 |
_aDraft Genome Sequence of VIM-2-Producing Multidrug-Resistant Pseudomonas aeruginosa ST175, an Epidemic High-Risk Clone. _h[artículo] |
260 |
_bGenome announcements, _c2013 |
||
300 | _a1(2):e0011213. | ||
500 | _aFormato Vancouver: Viedma E, Juan C, Otero JR, Oliver A, Chaves F. Draft Genome Sequence of VIM-2-Producing Multidrug-Resistant Pseudomonas aeruginosa ST175, an Epidemic High-Risk Clone. Genome Announc. 2013 Apr 11;1(2):e0011213. | ||
501 | _aPMID: 23580706 | ||
504 | _aContiene 12 referencias | ||
520 | _aThe VIM-2-producing multidrug-resistant high-risk clone Pseudomonas aeruginosa sequence type (ST) 175 was isolated in the setting of a large outbreak in Hospital Universitario 12 de Octubre (Spain) from 2007 to 2010. This strain was resistant to all beta-lactams, fluoroquinolones, and aminoglycosides, with the exception of amikacin, and has become an endemic clone in our institution. | ||
710 |
_9625 _aInstituto de Investigación imas12 |
||
710 |
_981 _aServicio de Microbiología y Parasitología |
||
856 |
_uhttp://europepmc.org/abstract/MED/23580706 _yAcceso libre |
||
942 |
_n0 _2ddc _cART |